vTv Therapeutics Inc. — Director's Dealing 2021

Mar 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: vTv Therapeutics Inc. (VTVT)
CIK: 0001641489
Period of Report: 2021-02-26

Reporting Person: KOZLOV HERSH (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-26	Class A common stock	P	10000.00	$2.74	Acquired	25000.00	Direct

Footnotes

F1: The price reported in column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $2.7298 to $2.7399, inclusive. The reporting person undertakes to provide to vTv Therapeutics Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote to this Form 4.